These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18020085)

  • 1. Sildenafil may facilitate weaning in mechanically ventilated COPD patients: a report of three cases.
    Stanopoulos I; Manolakoglou N; Pitsiou G; Trigonis I; Tsiata EA; Boutou AK; Kontou PK; Argyropoulou P
    Anaesth Intensive Care; 2007 Aug; 35(4):610-3. PubMed ID: 18020085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sildenafil on respiratory weaning of patients with chronic obstructive pulmonary diseases admitted to intensive care unit.
    Rafiei MR; Aghadavoudi O; Hojjat M
    Med Arh; 2012; 66(2):104-6. PubMed ID: 22486141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA
    Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil: a definitive NO in COPD.
    Vonk-Noordegraaf A; Boerrigter BG
    Eur Respir J; 2013 Oct; 42(4):893-4. PubMed ID: 24081756
    [No Abstract]   [Full Text] [Related]  

  • 5. Sildenafil for COPD: a randomized crossover trial.
    Bull T; Badesch DB
    COPD; 2012 Jun; 9(3):211-2. PubMed ID: 22587530
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD.
    Holverda S; Rietema H; Bogaard HJ; Westerhof N; Postmus PE; Boonstra A; Vonk-Noordegraaf A
    Pulm Pharmacol Ther; 2008; 21(3):558-64. PubMed ID: 18342559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sildenafil influence on the level of pulmonary artery pressure, bronchial patency and endothelial function during the action of risk factors for development of cardiorespiratory pathology].
    Baksheev VI; Kolomoets NM; Kartashov VT; Tursunova GF
    Voen Med Zh; 2006 Dec; 327(12):21-3. PubMed ID: 17338363
    [No Abstract]   [Full Text] [Related]  

  • 8. Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial.
    Lederer DJ; Bartels MN; Schluger NW; Brogan F; Jellen P; Thomashow BM; Kawut SM
    COPD; 2012 Jun; 9(3):268-75. PubMed ID: 22360383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial.
    Blanco I; Santos S; Gea J; Güell R; Torres F; Gimeno-Santos E; Rodriguez DA; Vilaró J; Gómez B; Roca J; Barberà JA
    Eur Respir J; 2013 Oct; 42(4):982-92. PubMed ID: 23429918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism.
    Ganière V; Feihl F; Tagan D
    Intensive Care Med; 2006 Mar; 32(3):452-4. PubMed ID: 16450094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil to facilitate weaning from inhaled nitric oxide and mechanical ventilation in a patient with severe secondary pulmonary hypertension and a patent foramen ovale.
    Elias S; Sviri S; Orenbuch-Harroch E; Fellig Y; Ben-Yehuda A; Fridlender ZG; Gilon D; Bayya A
    Respir Care; 2011 Oct; 56(10):1611-3. PubMed ID: 21513610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension.
    Oudiz RJ; Roveran G; Hansen JE; Sun XG; Wasserman K
    Eur J Heart Fail; 2007 Sep; 9(9):917-21. PubMed ID: 17707133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
    ; Zisman DA; Schwarz M; Anstrom KJ; Collard HR; Flaherty KR; Hunninghake GW
    N Engl J Med; 2010 Aug; 363(7):620-8. PubMed ID: 20484178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcome of 13 dogs with pulmonary arterial hypertension (PH) treated with sildenafil.
    Moreno HJ
    J Vet Intern Med; 2007; 21(6):1165. PubMed ID: 18196719
    [No Abstract]   [Full Text] [Related]  

  • 15. Sildenafil as a pulmonary vasodilator after repair of congenital heart disease.
    Kovacikova L; Zahorec M; Nosal M
    Bratisl Lek Listy; 2007; 108(10-11):453-4. PubMed ID: 18306725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity.
    Rietema H; Holverda S; Bogaard HJ; Marcus JT; Smit HJ; Westerhof N; Postmus PE; Boonstra A; Vonk-Noordegraaf A
    Eur Respir J; 2008 Apr; 31(4):759-64. PubMed ID: 18094009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil in idiopathic pulmonary fibrosis.
    Rossi GP; Seccia TM
    N Engl J Med; 2010 Nov; 363(22):2169-70; author reply 2170-1. PubMed ID: 21105803
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary arterial hypertension occurrence after liver transplant in systemic sclerosis: a report of 2 cases sustainably treated by sildenafil.
    Koumakis E; Wipff J; Kahan A; Allanore Y
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S53-4. PubMed ID: 20576215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil in idiopathic pulmonary fibrosis.
    Maher TM
    N Engl J Med; 2010 Nov; 363(22):2169; author reply 2170-1. PubMed ID: 21105804
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with oral sildenafil in patients with severe pulmonary hypertension after open heart operations].
    Zeng R; Zhuang J; Cen JZ; Chen XX; Xiong WP; Zhu WZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):916-9. PubMed ID: 16266481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.